Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Completed · Phase 3

Conditions studied: Anemia

In brief

To assess the safety and efficacy of two forms of iron therapy for the treatment of anemia in non-dialysis dependent, chronic renal failure in patients receiving or not receiving erythropoietin.

Key facts

Study ID

NCT00236977

Run by

American Regent, Inc.

People needed

182

Starts

2003-08-01

Expected to finish

2004-10-01

Last updated by the study team

2020-10-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hemoglobin < or = 11.5 gm/dL
• Stable dose or not receiving EPO
• Renal Anemia

You may not qualify if…

• IV iron with last 6 months
• Chronic infection, malignancy,major surgery within last month
• Blood Transfusion with last two months
• Significant blood loss within last 3 months
• Concomitant sever diseases of the liver

Where it is running

• Luitpold Pharmaceuticals — Valley Forge, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.